Key result
NAC restores calcium entry and nitric oxide release in calcific aortic valve endothelial cells.
Why the study?
Endothelial dysfunction and oxidative stress contribute to calcific aortic valve stenosis, and it had not yet been investigated whether the Ca2+ signalling toolkit is altered in human aortic valve endothelial cells from patients with this disease.
Does N-acetylcysteine restore store-operated Ca2+ entry (SOCE) and nitric oxide production in human aortic valve endothelial cells isolated from patients with severe calcific aortic valve stenosis?
Does N-acetylcysteine restore store-operated Ca2+ entry (SOCE) and nitric oxide production in human aortic valve endothelial cells isolated from patients with severe calcific aortic valve stenosis?
This study demonstrates for the first time that oxidative stress impairs store-operated Ca2+ entry (SOCE) and nitric oxide production in human aortic valve endothelial cells from patients with calcific aortic valve stenosis, and identifies N-acetylcysteine as a potential therapeutic agent to reverse this endothelial dysfunction.
Answers are grounded in this paper and cite their sources.
NAC may mitigate endothelial dysfunction in CAVS; hypothesis-generating and requires in vivo validation before clinical consideration.
Calcific aortic valve stenosis (CAVS), the most common valvular heart disease, is generally regarded as a progressive disease continuum evolving from aortic valve sclerosis (AVSc) to overt aortic stenosis (AS), characterized by increasing leaflet calcification and outflow obstruction. Endothelial dysfunction of the aortic valve plays a crucial role in the pathogenic mechanism leading to CAVS. A remarkable increase in oxidative stress contributes to endothelial injury in CAVS, thereby promoting endothelial-to-mesenchymal transition and impairing endothelium-dependent vasomotion and endothelial barrier function. Endothelial dysfunction can be accompanied by remodelling of the Ca 2+ handling machinery and restoring intracellular Ca 2+ signalling could represent a promising therapeutic strategy to recover endothelial function, including nitric oxide (NO) release. We adopted a multidisciplinary approach (i.e., RNA-seq analysis of Ca²⁺ toolkit-associated genes and single-cell Fura-2 Ca 2+ imaging for intracellular measurements) to investigate for the first time whether the Ca 2+ signalling toolkit is altered in human aortic valve endothelial cells (hVECs) from patients with CAVS (AS-hVECs) compared to VECs from control patients (hVECs; i.e., isolated from patients without stenosis). Bioinformatic analysis revealed that the transcripts encoding inositol-1,4,5-trisphosphate (InsP 3 ) receptors (InsP 3 Rs), i.e., ITPR1 , ITPR2 , and ITPR3 , which mediate Ca 2+ release from the endoplasmic reticulum (ER), were not altered, while the transcript encoding the ER Ca 2+ sensor STIM1, which initiates store-operated Ca 2+ entry (SOCE), was up-regulated in AS-hVECs. Capillary Western blot revealed that InsP 3 R and STIM1, but not Orai1 (the main pore-forming subunit of SOCE), proteins were significantly over-expressed in AS-hVECs. Unexpectedly, single-cell Fura-2 Ca 2+ imaging revealed that SOCE, a major driver of endothelial NO release, was remarkably down-regulated in AS-hVECs. Conversely, despite a reduction in the amount of releasable free ER Ca 2+ , physiological Ca 2+ release through InsP 3 Rs was unaffected, reflecting InsP 3 R hyper-responsiveness in AS-hVECs. However, N-acetyl-L-cysteine (NAC), a widely employed ROS scavenger, and the thiol-reducing agent dithiothreitol (DTT) fully rescued SOCE, consistent with the ROS-dependent inhibition of SOCE activation. Furthermore, pre-treatment with NAC also restored acetylcholine-induced NO release. These findings reveal that oxidative stress impairs SOCE in AS-hVECs and identify NAC as a potential therapeutic strategy to prevent endothelial dysfunction in this heart valve disease.
No takes yet. Share an insight, caveat, or question.
Faris et al. (2026) studied Calcific aortic valve stenosis (CAVS) (n=8). N-acetyl-L-cysteine (NAC) vs. Untreated AS-hVECs and control hVECs from patients without stenosis was evaluated on Store-operated Ca2+ entry (SOCE) amplitude and acetylcholine-induced nitric oxide (NO) release in human aortic valve endothelial cells (p=<0.001). N-acetyl-L-cysteine (NAC) rescued downregulated store-operated Ca2+ entry and restored acetylcholine-induced nitric oxide release in aortic valve endothelial cells from patients with CAVS.
Synapse has enriched 10 related papers. Consider them for comparative context: